World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
60
Citations
10201
World Ranking
3366
National Ranking
1555

Overview

Suyu Shu is affiliated with the University of Michigan-Ann Arbor in the United States. Their academic profile is characterized by research activity conducted under this primary affiliation.

There is no available data regarding specific recent papers, co-authors, or frequent publication venues linked to their scholarly output. Similarly, information about book publications, fields of study, subfields, or main topics addressed in their work is not provided.

Details about any awards or recognitions are absent as well.

As such, the available information primarily identifies Suyu Shu by their institutional association without further elaboration on research contributions or scholarly impact.

Best Publications

  • Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

    Gary J. Nabel;Elizabeth G. Nabel;Zhi Yong Yang;Bernard A. Fox

  • Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2.

    James J. Mulé;Suyu Shu;Susan L. Schwarz;Steven A. Rosenberg

  • Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth.

    Jørgen Kjærgaard;Junta Tanaka;Julian A. Kim;Kevin Rothchild

  • Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2.

    Hirohisa Yoshizawa;Alfred E. Chang;Suyu Shu

  • Depletion of CD4+ CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes.

    Hiroshi Tanaka;Junta Tanaka;Jørgen Kjaergaard;Suyu Shu

  • Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2.

    J. J. Mule;J. C. Yang;R. L. Afreniere;Suyu Shu

  • Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2.

    A E Chang;A Aruga;M J Cameron;V K Sondak

  • CD4+ T cells in adoptive immunotherapy and the indirect mechanism of tumor rejection.

    Peter A. Cohen;Liaomin Peng;Gregory E. Plautz;Julian A. Kim

  • Immunotherapy of Malignancy by In Vivo Gene Transfer into Tumors

    Gary J. Nabel;Alfred Chang;Elizabeth G. Nabel;Gregory Plautz

  • Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes.

    Satoshi Watanabe;Katsuya Deguchi;Rongxiu Zheng;Hidemasa Tamai

  • Systemic T cell adoptive immunotherapy of malignant gliomas

    Gregory E. Plautz;Gene H. Barnett;David W. Miller;Bruce H. Cohen

  • T cell adoptive immunotherapy of newly diagnosed gliomas.

    Gregory E. Plautz;David W. Miller;Gene H. Barnett;Glen H. J. Stevens

  • Infiltration of Tumors by Systemically Transferred Tumor-Reactive T Lymphocytes Is Required for Antitumor Efficacy

    Shigehiko Mukai;Jørgen Kjærgaard;Suyu Shu;Gregory E. Plautz

  • CXC Chemokine Ligand 9/Monokine Induced by IFN-γ Production by Tumor Cells Is Critical for T Cell-Mediated Suppression of Cutaneous Tumors

    Anton V. Gorbachev;Hirohito Kobayashi;Daisuke Kudo;Charles S. Tannenbaum

  • Purification of L-Selectin low Cells Promotes the Generation of Highly Potent CD4 Antitumor Effector T Lymphocytes

    Hiroshi Kagamu;Suyu Shu

  • Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules.

    Maria R. Parkhurst;Cormac DePan;John P. Riley;Steven A. Rosenberg

  • Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation.

    Julian A. Kim;Bruce J. Averbook;Kathleen Chambers;Kevin Rothchild

  • Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro.

    Alfred E. Chang;Hirohisa Yoshizawa;Keisuke Sakai;Mark J. Cameron

  • Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity.

    S Y Shu;T Chou;K Sakai

  • Augmentation Versus Inhibition: Effects of Conjunctional OX-40 Receptor Monoclonal Antibody and IL-2 Treatment on Adoptive Immunotherapy of Advanced Tumor

    Jørgen Kjaergaard;Liaomin Peng;Peter A. Cohen;Judith A. Drazba

Frequent Co-Authors

Peter A. Cohen
Peter A. Cohen Mayo Clinic
Alfred E. Chang
Alfred E. Chang University of Michigan–Ann Arbor
Alfred E. Chang
Alfred E. Chang University of Michigan–Ann Arbor
Vernon K. Sondak
Vernon K. Sondak University of South Florida
Gene H. Barnett
Gene H. Barnett Cleveland Clinic
Gary J. Nabel
Gary J. Nabel ModeX Therapeutics
John F. Tisdale
John F. Tisdale National Institutes of Health
Xin Yuan Fu
Xin Yuan Fu National University of Singapore
Elizabeth G. Nabel
Elizabeth G. Nabel Brigham and Women's Hospital
Leaf Huang
Leaf Huang University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare fields can open diverse career opportunities. Nursing, especially psychiatric nurse practitioner roles, is a growing area that complements immunological knowledge. Prospective students often seek the easiest NP programs to get into to begin their advanced nursing education without excessive barriers.

Many online programs stand out for their quality clinical experiences. When choosing where to study, looking into the top online PMHNP programs ensures strong practical training and better job readiness.

Cost is another major factor for students. Thankfully, there are several affordable PMHNP programs that provide quality education without the heavy financial burden, making advanced nursing degrees more accessible.

Career outlook is promising, especially for those pursuing a Doctor of Nursing Practice (DNP). Understanding the highest paid DNP specialties can help guide students toward high-demand roles with competitive salaries, maximizing the return on their educational investment.

Best Scientists Citing Suyu Shu

Trending Scientists

Recently Published Articles